Adlouni, HA, Katrib, K & Ferard, G (1988) Changes in carnitine in polymorphonuclear leukocytes, mononuclear cells, and plasma from patients with inflammatory disorders. Clin Chem 34, 40–43.
Ahmad, T, Armuzzi, A, Bunce, M, et al. (2002) The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 122, 854–866.
Arnott, ID, Nimmo, ER, Drummond, HE, et al. (2004) NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun 5, 417–425.
Bene, J, Komlosi, K, Gasztonyi, B, Juhasz, M, Tulassay, Z & Melegh, B (2005) Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet. World J Gastroenterol 11, 6671–6675.
Bieber, LL (1988) Carnitine. Annu Rev Biochem 57, 261–283.
Brant, SR, Picco, MF, Achkar, JP, et al. (2003) Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis 9, 281–289.
Bremer, J (1983) Carnitine-metabolism and functions. Physiol Rev 63, 1420–1480.
Costa, CC, de Almeida, IT, Jakobs, C, Poll-The, BT & Duran, M (1999) Dynamic changes of plasma acylcarnitine levels induced by fasting and sunflower oil challenge test in children. Pediatr Res 46, 440–444.
Demirkol, M, Sewell, AC & Bohles, H (1994) The variation of carnitine content in human blood cells during disease – a study in bacterial infection and inflammatory bowel disease. Eur J Pediatr 153, 565–568.
Di Sabatino, A, Morera, R, Ciccocioppo, R, Cazzola, P, Gotti, S, Tinozzi, FP, Tinozzi, S & Corazza, GR (2005) Oral butyrate for mildly to moderately active Crohn's disease. Aliment Pharmacol Ther 22, 789–794.
Fritz, IB & Yue, KT (1963) Long-chain carnitine acyltransferase and the role of acylcarnitine derivatives in the catalytic increase of fatty acid oxidation induced by carnitine. J Lipid Res 4, 279–288.
Hampe, J, Cuthbert, A, Croucher, PJ, et al. (2001) Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357, 1925–1928.
Hugot, JP, Chamaillard, M, Zouali, H, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599–603.
Inoue, N, Tamura, K, Kinouchi, Y, et al. (2002) Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 123, 86–91.
Leong, RW, Armuzzi, A, Ahmad, T, Wong, ML, Tse, P, Jewell, DP & Sung, JJ (2003) NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 17, 1465–1470.
Lesage, S, Zouali, H, Cezard, JP, et al. (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70, 845–857.
Melegh, B, Kerner, J & Bieber, LL (1987) Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochem Pharmacol 36, 3405–3409.
Mendoza, JL, Murillo, LS, Fernandez, L, Pena, AS, Lana, R, Urcelay, E, Cruz-Santamaria, DM, de la Concha, EG, Diaz-Rubio, M & Garcia-Paredes, J (2003) Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn disease. Scand J Gastroenterol 38, 1235–1240.
Newman, B, Gu, X, Wintle, R, Cescon, D, Yazdanpanah, M, Liu, X, Peltekova, V, Van Oene, M, Amos, CI & Siminovitch, KA (2005) A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology 128, 260–269.
Noble, CL, Nimmo, ER, Drummond, H, Ho, GT, Tenesa, A, Smith, L, Anderson, N, Arnott, ID & Satsangi, J (2005) The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 129, 1854–1864.
Ogura, Y, Bonen, DK, Inohara, N, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603–606.
Peltekova, VD, Wintle, RF, Rubin, LA, et al. (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36, 471–475.
Rashed, MS (2001) Clinical applications of tandem mass spectrometry: ten years of diagnosis and screening for inherited metabolic diseases. J Chromatogr B Biomed Sci Appl 758, 27–48.
Schreiber, S, Nikolaus, S & Hampe, J (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42, 477–484.
Segain, JP, Raingeard de la Bletiere, D, Bourreille, A, Leray, V, Gervois, N, Rosales, C, Ferrier, L, Bonnet, C, Blottiere, HM & Galmiche, JP (2000) Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47, 397–403.
Tamai, I, Ohashi, R, Nezu, J, Yabuuchi, H, Oku, A, Shimane, M, Sai, Y & Tsuji, A (1998) Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273, 20378–20382.
Torok, HP, Glas, J, Tonenchi, L, et al. (2005) Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut 54, 1421–1427.
Vermeire, S, Pierik, M, Hlavaty, T, et al. (2005) Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Gastroenterology 129, 1845–1853.
Vermeire, S, Wild, G, Kocher, K, et al. (2002) CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 71, 74–83.
Vind, I, Vieira, A, Hougs, L, et al. (2005) NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype–phenotype analysis in Danish and Portuguese patients and controls. Digestion 72, 156–163.
Yamazaki, K, Takazoe, M, Tanaka, T, Ichimori, T, Saito, S, Iida, A, Onouchi, Y, Hata, A & Nakamura, Y (2004) Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease. J Hum Genet 49, 664–668.
Wu, X, George, RL, Huang, W, Wang, H, Conway, SJ, Leibach, FH & Ganapathy, V (2000) Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta 1466, 315–327.
Wu, X, Prasad, PD, Leibach, FH & Ganapathy, V (1998) cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246, 589–595.